For example, variants in PNPLA3 (Patatin-like phospholipase domain-containing 3) and TM6SF2 (transmembrane 6 superfamily member 2) have been tightly associated with the occurrence and progression of NAFLD [4,5]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.